Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Product containing precisely naproxen sodium 500 milligram and sumatriptan succinate 85 milligram/1 each conventional release oral tablet (clinical drug) |
Is a |
Product containing naproxen sodium and sumatriptan |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely naproxen sodium 500 milligram and sumatriptan succinate 85 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Naproxen sodium (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely naproxen sodium 500 milligram and sumatriptan succinate 85 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Sumatriptan succinate |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely naproxen sodium 500 milligram and sumatriptan succinate 85 milligram/1 each conventional release oral tablet (clinical drug) |
Has manufactured dose form |
Conventional release oral tablet (dose form) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely naproxen sodium 500 milligram and sumatriptan succinate 85 milligram/1 each conventional release oral tablet (clinical drug) |
Is a |
Sumatriptan-containing product in oral dose form |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely naproxen sodium 500 milligram and sumatriptan succinate 85 milligram/1 each conventional release oral tablet (clinical drug) |
Is a |
Naproxen-containing product in oral dose form |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely naproxen sodium 500 milligram and sumatriptan succinate 85 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit (attribute) |
mg |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Product containing precisely naproxen sodium 500 milligram and sumatriptan succinate 85 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator value |
un |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Product containing precisely naproxen sodium 500 milligram and sumatriptan succinate 85 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator unit (attribute) |
Tablet (unit of presentation) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Product containing precisely naproxen sodium 500 milligram and sumatriptan succinate 85 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit (attribute) |
mg |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Product containing precisely naproxen sodium 500 milligram and sumatriptan succinate 85 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator value |
un |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Product containing precisely naproxen sodium 500 milligram and sumatriptan succinate 85 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator unit (attribute) |
Tablet (unit of presentation) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Product containing precisely naproxen sodium 500 milligram and sumatriptan succinate 85 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Naproxen sodium (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Product containing precisely naproxen sodium 500 milligram and sumatriptan succinate 85 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
Naproxen sodium (substance) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Product containing precisely naproxen sodium 500 milligram and sumatriptan succinate 85 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value |
500 |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Product containing precisely naproxen sodium 500 milligram and sumatriptan succinate 85 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Sumatriptan succinate |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Product containing precisely naproxen sodium 500 milligram and sumatriptan succinate 85 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
Sumatriptan succinate |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Product containing precisely naproxen sodium 500 milligram and sumatriptan succinate 85 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value |
85 |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Product containing precisely naproxen sodium 500 milligram and sumatriptan succinate 85 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
Sumatriptan succinate |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Product containing precisely naproxen sodium 500 milligram and sumatriptan succinate 85 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
Naproxen sodium (substance) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Product containing precisely naproxen sodium 500 milligram and sumatriptan succinate 85 milligram/1 each conventional release oral tablet (clinical drug) |
Has unit of presentation |
Tablet (unit of presentation) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely naproxen sodium 500 milligram and sumatriptan succinate 85 milligram/1 each conventional release oral tablet (clinical drug) |
Is a |
Naproxen- and sumatriptan-containing product in oral dose form |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely naproxen sodium 500 milligram and sumatriptan succinate 85 milligram/1 each conventional release oral tablet (clinical drug) |
Count of base of active ingredient |
deux |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely naproxen sodium 500 milligram and sumatriptan succinate 85 milligram/1 each conventional release oral tablet (clinical drug) |
Is a |
Naproxen and sumatriptan only product in oral dose form |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing precisely naproxen sodium 500 milligram and sumatriptan succinate 85 milligram/1 each conventional release oral tablet (clinical drug) |
Plays role |
Antimigraine therapeutic role |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|